Arch Biopartners Inc. ACHFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.04M | -1.87M | -1.87M | -1.05M | -1.67M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 786.20K | 1.08M | 758.70K | -97.90K | 358.40K |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -1.25M | -793.50K | -1.12M | -1.15M | -1.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 205.20K | 205.20K | 163.10K | 638.50K | 567.60K |
| Total Debt Repaid | -280.90K | -495.20K | -495.20K | -252.30K | -286.90K |
| Issuance of Common Stock | 1.66M | 1.83M | 1.86M | 1.25M | 1.68M |
| Repurchase of Common Stock | -14.30K | -14.30K | -14.30K | -14.30K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.13M | 1.10M | 1.08M | 1.15M | 1.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.60K | 310.60K | -36.00K | -400.00 | 89.70K |